Coronary Artery Disease Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stages, Drug Mechanism Classes, Company – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Coronary Artery Disease Clinical Trial Pipeline Highlights – 2019”
report has been added to ResearchAndMarkets.com’s
offering.

Coronary Artery Disease Pipeline Highlights – 2019, provides most
up-to-date information on key pipeline products in the global Coronary
Artery Disease market. It covers emerging therapies for Coronary Artery
Disease in active clinical development stages including early and late
stage clinical trials. The pipeline data presented in this report helps
executives for tracking competition, identifying partners, evaluating
opportunities, formulating business development strategies, and
executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Coronary Artery Disease pipeline products by
clinical trial stages including both early and late stage development –
phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical
trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Coronary Artery Disease pipeline products by their
dominant mechanism of action/drug class. This helps executives
categorize products based on their drug class and also assess the
strengths and weaknesses of compounds.

Company:

The report provides Coronary Artery Disease pipeline products by the
company.

Short-term Launch Highlights:

Find out which Coronary Artery Disease pipeline products will be
launched in the US and Ex-US till 2024.

Key Topics Covered:

1. Coronary Artery Disease Pipeline by Stages

2. Coronary Artery Disease Phase 3 Clinical Trial Insights

3. Coronary Artery Disease Phase 2 Clinical Trial Insights

4. Coronary Artery Disease Phase 1 Clinical Trial Insights

5. Coronary Artery Disease Preclinical Research Insights

6. Coronary Artery Disease Discovery Stage Insights

7. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/m21p5s

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Cardiovascular
Drugs , Clinical
Trials